Cholestyramine Light Powder, For Suspension
Product Images NDC 51224-009

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cholestyramine Light (NDC 51224-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tagi Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cholestyramine Light 01

Chemical structure of cholestyramine displayed as a polymer chain with repeating aromatic rings and quaternary ammonium chloride groups, consistent with the active ingredient cholestyramine in Cholestyramine Light powder for suspension oral dosage form.*

FDA Label Image

Cholestyramine Light 02

Packaging label for Cholestyramine for Oral Suspension USP, Light powder, 4 grams cholestyramine resin USP per pouch. The label states orange flavor, prescription only, 60 single-dose pouches per package, and is manufactured for TAGI Pharma, Inc. It includes preparation instructions with images for mixing the powder with water or other liquids, storage conditions, and healthful hints. The label features a barcode and manufacturing information from Laboratorios Rubió, Spain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.